We observed that the MOS-Fc-CDHA nanocomposites exhibited no cytotoxicity against the normal NIH-3T3 and melanoma B16F10 cells and the selective cellular uptake in the B16F10 cells via the CD44-receptor mediated endocytosis pathway. This evidence concerns the gene CD44 and melanoma.